Atlanta, GA, United States of America

Margaret McCrann Pugh


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Margaret McCrann Pugh

Introduction

Margaret McCrann Pugh is a notable inventor based in Atlanta, GA. She has made significant contributions to the field of medical science, particularly in the area of leukotriene inhibition. With a total of three patents to her name, her work has the potential to impact various therapeutic approaches.

Latest Patents

Among her latest patents, one focuses on methods of inhibiting leukotriene A4 hydrolase. This invention is directed towards treating conditions that can be ameliorated by the inhibition of leukotriene A4 hydrolase activity in human patients. The method involves administering a specific compound, 4-{5-[4-(4-Oxazol-2-yl-phenoxy)-benzyl]-2,5-diaza-bicyclo[2.2.1]hept-2-ylmethyl}-benzoic acid, to patients. This innovative approach showcases her commitment to advancing medical treatments.

Career Highlights

Throughout her career, Margaret has worked with several companies, including Celtaxsys, Inc. and Celltaxis, LLC. Her experience in these organizations has allowed her to develop and refine her inventions, contributing to the advancement of medical science.

Collaborations

Margaret has collaborated with notable professionals in her field, including Eric B. Springman and Lopa Bhatt. These collaborations have likely enriched her work and expanded the impact of her inventions.

Conclusion

Margaret McCrann Pugh is a distinguished inventor whose work in inhibiting leukotriene A4 hydrolase has the potential to transform medical treatments. Her contributions reflect her dedication to innovation and the betterment of human health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…